Literature DB >> 17441797

Evaluation of the IgE cross-reactions among vespid venoms. A possible approach for the choice of immunotherapy.

B Caruso1, P Bonadonna, M G Severino, M Manfredi, A Dama, M Schiappoli, P Rizzotti, G Senna, G Passalacqua.   

Abstract

BACKGROUND: Hymenoptera venom allergy can be effectively cured with specific immunotherapy, thus the correct identification of the allergen is essential. In the case of multiple skin and serum positivities it is important to know if a cross-reaction among venoms is present. We studied by CAP-inhibition assays the degree of cross-reactivity between Vespula vulgaris and Polistes dominulus.
METHODS: Serum samples were obtained from consecutive patients with a clinical history of grade III-IV reactions to hymenoptera sting and with nondiscriminative skin/CAP positivity to both Vespula and Polistes. Inhibition assays were carried out with a CAP method, incubating the sera separately with both venoms and subsequently measuring the specific immunoglobulin E (IgE) to venoms themselves.
RESULTS: Forty-five patients (33 male, mean age 40 years, age range 12-74, total serum IgE 242 +/- 168 kU/l) were included. Their specific IgE to Vespula and Polistes were 12.03 +/- 5.70 kU/l and 10.7 +/- 2.0 kU/l (P = NS), respectively. At the CAP-inhibition assays, in 25 patients a >75% heterologous inhibition by P. dominulus venom against V. vulgaris-specific IgE was found. In six subjects V. vulgaris venom effectively inhibited the P. dominulus-specific IgE. In the remaining 14 cases the CAP-inhibition test provided intermediate and not discriminative results.
CONCLUSION: In 31/45 patients, the double sensitizations to venoms were probably the result of cross-reactions and the CAP-inhibition allowed identifying the true double sensitizations. This approach may be helpful for the correct prescription of immunotherapy in the case of V. vulgaris and P. dominulus double positivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441797     DOI: 10.1111/j.1398-9995.2007.01353.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  16 in total

Review 1.  Clinical immunology review series: an approach to desensitization.

Authors:  M T Krishna; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

2.  [Cross reactions between Hymenoptera venoms from different families, genera and species].

Authors:  W Hemmer
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

3.  Comprehensive 3D-modeling of allergenic proteins and amino acid composition of potential conformational IgE epitopes.

Authors:  Numan Oezguen; Bin Zhou; Surendra S Negi; Ovidiu Ivanciuc; Catherine H Schein; Gilles Labesse; Werner Braun
Journal:  Mol Immunol       Date:  2008-07-14       Impact factor: 4.407

Review 4.  Anaphylaxis to insect venom allergens: role of molecular diagnostics.

Authors:  Markus Ollert; Simon Blank
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 5.  Hymenoptera allergens: from venom to "venome".

Authors:  Edzard Spillner; Simon Blank; Thilo Jakob
Journal:  Front Immunol       Date:  2014-02-28       Impact factor: 7.561

6.  Comparing the ability of molecular diagnosis and CAP-inhibition in identifying the really causative venom in patients with positive tests to Vespula and Polistes species.

Authors:  Eleonora Savi; Silvia Peveri; Elena Makri; Valerio Pravettoni; Cristoforo Incorvaia
Journal:  Clin Mol Allergy       Date:  2016-02-08

7.  The high molecular weight dipeptidyl peptidase IV Pol d 3 is a major allergen of Polistes dominula venom.

Authors:  Maximilian Schiener; Christiane Hilger; Bernadette Eberlein; Mariona Pascal; Annette Kuehn; Dominique Revets; Sébastien Planchon; Gunilla Pietsch; Pilar Serrano; Carmen Moreno-Aguilar; Federico de la Roca; Tilo Biedermann; Ulf Darsow; Carsten B Schmidt-Weber; Markus Ollert; Simon Blank
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

8.  Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study.

Authors:  Eleonora Savi; Cristoforo Incorvaia; Elisa Boni; Marina Mauro; Silvia Peveri; Valerio Pravettoni; Oliviero Quercia; Federico Reccardini; Marcello Montagni; Laura Pessina; Erminia Ridolo
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

9.  Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics.

Authors:  Thilo Jakob; David Rafei-Shamsabadi; Edzard Spillner; Sabine Müller
Journal:  Allergo J Int       Date:  2017-04-11

Review 10.  Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.

Authors:  Maximilian Schiener; Anke Graessel; Markus Ollert; Carsten B Schmidt-Weber; Simon Blank
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.